Using quantitative proteomics to optimize Euglena gracilis as a sole-source COVID-19 vaccine delivery platform
- Funded by Natural Sciences and Engineering Research Council of Canada (NSERC)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$38,000Funder
Natural Sciences and Engineering Research Council of Canada (NSERC)Principal Investigator
Richard UhrigResearch Location
CanadaLead Research Institution
AlbertaResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementationResearch Subcategory
Vaccine design and administrationSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
Medical and health sciences; Life sciences (including biotechnology)